Genus Capital Management’s Sherwin-Williams SHW Stock Holding History

Genus Capital Management’s Portfolio SHW Stock Details SHW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-4,230	Closed	-$1.36M	–	225
2026 Q1	$1.36M	Buy	+4,230	New	+$1.46M	0.16%	131
2025 Q3	–	Sell	-8,365	Closed	-$2.87M	–	226
2025 Q2	$2.87M	Buy	8,365 +1,835	+28%	+$636K	0.37%	85
2025 Q1	$2.28M	Buy	+6,530	New	+$2.29M	0.33%	87

Other funds holding SHW

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Genus Capital Management's SHW Position: Q2 2026 in Review

Genus Capital Management sold out of Sherwin-Williams (SHW) in Q2 2026, closing a stake of 4,230 shares — an estimated $1.36M sold.

Genus Capital Management first reported a position in SHW in Q1 2025 and held it in 3 quarters. The position peaked at $2.87M in Q2 2025. 1,733 funds tracked by Wall St. Rank hold SHW as of Q2 2026.

Genus Capital Management reported no remaining Sherwin-Williams position as of Q2 2026 after selling out during the quarter.
Genus Capital Management sold 4,230 Sherwin-Williams shares in Q2 2026, an estimated $1.36M.
Genus Capital Management first reported a position in Sherwin-Williams in Q1 2025 and held it in 3 quarters.
Genus Capital Management's Sherwin-Williams position peaked at $2.87M in Q2 2025.
1,733 funds tracked by Wall St. Rank held Sherwin-Williams as of Q2 2026.

Based on Genus Capital Management's 13F filing for Q2 2026, filed 29 Jul 2026.